News and events

closerlook is proud to have been featured recently in Medical Marketing & Media’s 2013 Top 100 Agencies issue

Medical Marketing & Media - July, 2013


 

closerlook is proud to have been featured recently in Medical Marketing & Media’s 2013 Top 100 Agencies issue.

Recognized for proficiency in relationship marketing and data, closerlook was reported as being in a prime position to usher clients through the next wave of data marketing.
 
“I really responded to their recognition of closerlook as ‘ushering clients’ through the next wave of data marketing,” CEO David Ormesher commented. “We do look at ourselves as empowering our clients and their data, partnering with them as a trusted advisor that can help them execute smarter marketing decisions. We’re building a solid track record of doing just that.”

closerlook has long been of the opinion that individual conversations are what’s important; that you can’t market with a broad brush and expect to get the kind of results that make a difference.  Ormesher said, “Data has to be collected rigorously across multiple touchpoints.  When I talk about touchpoints, I’m talking about everything from a sales rep call to a sample drop at a conference...every place we’re somehow communicating with a physician” he says, so that closerlook knows “what kind of response they get by physician – we’re not looking for an aggregate.”

 

See all articles

The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.

Let’s start the conversation. Contact us